Aggarwal Pritti, Woolford Stephen J, Patel Harnish P
Southampton City Clinical Commissioning Group, Southampton SO16 4GX, UK.
Living Well Partnership, Southampton SO19 9GH, UK.
Geriatrics (Basel). 2020 Oct 28;5(4):85. doi: 10.3390/geriatrics5040085.
Multi-morbidity and polypharmacy are common in older people and pose a challenge for health and social care systems, especially in the context of global population ageing. They are complex and interrelated concepts in the care of older people that require early detection and patient-centred shared decision making underpinned by multi-disciplinary team-led comprehensive geriatric assessment (CGA) across all health and social care settings. Personalised care plans need to remain responsive and adaptable to the needs and wishes of the patient, enabling the individual to maintain their independence. In this review, we aim to give an up-to-date account of the recognition and management of multi-morbidity and polypharmacy in the older person.
多重疾病和多重用药在老年人中很常见，对卫生和社会护理系统构成挑战，尤其是在全球人口老龄化的背景下。在老年人护理中，它们是复杂且相互关联的概念，需要早期发现，并以患者为中心进行共同决策，这一决策以跨所有卫生和社会护理环境的多学科团队主导的综合老年评估（CGA）为基础。个性化护理计划需要始终响应并适应患者的需求和愿望，使个体能够保持独立。在本综述中，我们旨在提供关于老年人多重疾病和多重用药的识别与管理的最新情况。
